These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 24598801
1. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Juul KV, Bichet DG, Nielsen S, Nørgaard JP. Am J Physiol Renal Physiol; 2014 May 01; 306(9):F931-40. PubMed ID: 24598801 [Abstract] [Full Text] [Related]
2. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Gattone VH, Maser RL, Tian C, Rosenberg JM, Branden MG. Dev Genet; 1999 May 01; 24(3-4):309-18. PubMed ID: 10322639 [Abstract] [Full Text] [Related]
3. Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation. Memetimin H, Izumi Y, Nakayama Y, Kohda Y, Inoue H, Nonoguchi H, Tomita K. Am J Physiol Renal Physiol; 2009 Sep 01; 297(3):F620-8. PubMed ID: 19587140 [Abstract] [Full Text] [Related]
4. Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise. Hew-Butler T, Hummel J, Rider BC, Verbalis JG. Am J Physiol Regul Integr Comp Physiol; 2014 Aug 15; 307(4):R366-75. PubMed ID: 24944242 [Abstract] [Full Text] [Related]
5. Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach. Mutig K, Borowski T, Boldt C, Borschewski A, Paliege A, Popova E, Bader M, Bachmann S. Am J Physiol Renal Physiol; 2016 Aug 01; 311(2):F411-23. PubMed ID: 27306979 [Abstract] [Full Text] [Related]
6. Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration. Tian Y, Serino R, Verbalis JG. Am J Physiol Renal Physiol; 2004 Oct 01; 287(4):F797-805. PubMed ID: 15213068 [Abstract] [Full Text] [Related]
7. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus. Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, de Zegher F, Corydon TJ. Am J Physiol Renal Physiol; 2009 Dec 01; 297(6):F1518-25. PubMed ID: 19812297 [Abstract] [Full Text] [Related]
10. Characterization of a functional V1B vasopressin receptor in the male rat kidney: evidence for cross talk between V1B and V2 receptor signaling pathways. Hus-Citharel A, Bouby N, Corbani M, Mion J, Mendre C, Darusi J, Tomboly C, Trueba M, Serradeil-Le Gal C, Llorens-Cortes C, Guillon G. Am J Physiol Renal Physiol; 2021 Sep 01; 321(3):F305-F321. PubMed ID: 34282956 [Abstract] [Full Text] [Related]
11. Increased renal responsiveness to vasopressin and enhanced V2 receptor signaling in RGS2-/- mice. Zuber AM, Singer D, Penninger JM, Rossier BC, Firsov D. J Am Soc Nephrol; 2007 Jun 01; 18(6):1672-8. PubMed ID: 17475820 [Abstract] [Full Text] [Related]
13. Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption. Ranieri M, Tamma G, Pellegrino T, Vezzi V, Ambrosio C, Grò C, Di Mise A, Costa T, Valenti G, Cotecchia S. Pflugers Arch; 2019 Oct 01; 471(10):1291-1304. PubMed ID: 31486901 [Abstract] [Full Text] [Related]